News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.
2 hrs ago | Barron's
Last week's rally is looking more like the real deal and less like a mirage as stock futures tick higher this morning.
Trending on the Topix Network
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday April 18 through Sunday April 20, 2014.
Pfizer Inc., the world's biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, according to two people familiar with the matter.
US pharmaceuticals giant Pfizer is mulling a A 60billion bid approach for struggling UK drugs group AstraZeneca, writes Ruth Sunderland.
ReportsnReports.com offers Therapeutic Class Overview: Psoriasis - Plaque Psoriasis & Psoriatic Arthritis: Novel Oral drugs and Biologics to Change Future Treatment Paradigm market research report in its store.
Mr. Lawrence Weinstein, who served as President & COO of ALR Technologies since 2010, expressed a wish to pursue other activities and will remain as a consultant.
Every year that multinational corporations and wealthy individuals lower their U.S. tax bills by stashing profits in off-shore tax havens , you pay more to cover their tab.
Last week, I noted the market was likely to bounce. It did, and my sole reason was that it was butting up against the downtrend line.
Biogen Idec Inc is pricing its newly-approved long-acting hemophilia drug to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.
There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.
Mr. Allary currently is in Paris working as independent consultant and executive coach in life sciences.
Members of Congress have complained for years about U.S. corporations that park profits overseas to avoid paying federal taxes.
Health care is the largest component of the American economy, about one-sixth the gross domestic product.
Craig Lipset, head of clinical innovation at Pfizer Inc., will join advocates of patient data accessibility to highlight the Blue Button initiative at the DIA 2014 50th Annual Meeting in San Diego.
Scientists and drugmakers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of bringing them to market.